Načítá se...

Untargeted metabolomics reveals a new mode of action of pretomanid (PA-824)

Pretomanid is a promising anti-tubercular drug currently at clinical phase III, but its mechanisms of action are currently unclear. This study aimed to: (i) reveal the metabolome of Mycobacterium smegmatis under pretomanid treatment; (ii) compare major sources of metabolite variation in bacteria tre...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Baptista, Rafael, Fazakerley, David M., Beckmann, Manfred, Baillie, Les, Mur, Luis A. J.
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5865180/
https://ncbi.nlm.nih.gov/pubmed/29572459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-23110-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!